With its Orano Med subsidiary, Orano is at the forefront of research in nuclear medicine and is developing new therapies against cancer. In 2013, a unique laboratory in the world, specialized in the production of lead-212, was inaugurated in Bessines-sur-Gartempe. This radioactive isotope coming from thorium is very promising in alpha therapy, an innovative form of radiotherapy that limits the impact on healthy cells.
By clicking “I accept Cookies”, you agree with the cookies use to enhance site navigation, analyze site usage and compile statistics. To get more information, please read our Cookies Policy in the Legal Notice